Dasacent (Tablet 140 mg)

Dasacent is indicated for the treatment of adult patients with- Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase. Chronic, accelerated, or myeloid or lymphoid blast phase Ph+ CML with resistance or intolerance to prior therapy including Imatinib. Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance or intolerance to prior therapy. Dasacent is indicated for the treatment of pediatric patients 1 year of age and older with Ph+ CML in chronic phase. Newly diagnosed Ph+ ALL in combination with chemotherapy. * রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'

Add to cart